Format

Send to

Choose Destination
J Refract Surg. 2007 Jun;23(6):617-9.

Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma.

Author information

1
Department of Cornea and Refractive Surgery, VISSUM Instituto Oftalmol├│gico de Alicante, Spain. rdioa@vissum.com

Abstract

PURPOSE:

To ascertain the usefulness of platelet-rich plasma in the treatment of patients suffering from symptomatic ocular surface syndrome following LASIK.

METHODS:

Twenty-six eyes (9 women and 4 men) affected by symptomatic ocular surface syndrome were treated with topical eye drops of autologous platelet-rich plasma and results were reported at 4 weeks. Topical platelet-rich plasma was prepared from total blood and enriched in platelets by centrifugation.

RESULTS:

Eighty-five percent of patients experienced significant improvement of symptoms; best spectacle-corrected visual acuity increased 1 to 2 lines in 54%; fluorescein staining analysis showed a 69% full fluorescein disappearance; and tear break-up time increased > 2 seconds in 46%. Only one patient developed intolerance to platelet-rich plasma after 4 weeks.

CONCLUSIONS:

Autologous platelet-rich plasma was effective in the treatment of patients with ocular surface syndrome following LASIK, with symptoms generally relieved and a positive effect on punctate keratitis.

PMID:
17598582
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center